Muhammad Adrish, MD, MBA

@DanckersMD @JHUeducation @accpchest @atscommunity @APCCMPD Congratulations my friend!

As I approach graduation, my Master’s in Education in the Health Professions #MEHP at @JHUeducation gave me a wonderful and unexpected surprise: I was honored with the 2026 Excellence Award. @accpchest @atscommunity @APCCMPD

Presented at #ACC26: In patients with pulmonary embolism, ultrasound-facilitated, catheter-directed fibrinolysis led to a lower risk of a composite of major adverse outcomes than anticoagulation alone. Full HI-PEITHO trial results: nejm.org/doi/full/10.10… Editorial: Advanced Therapy for Intermediate-Risk Pulmonary Embolism nejm.org/doi/full/10.10… @ACCinTouch

Mark Your Calendars: Advances in Pulmonary Medicine on Saturday, February 21, 2026 >Learn from world-renowned experts >Attend in-person or virtually >8.00 AMA Cat 1 Credits >Registration Open: Free for any trainees/students >Scan barcode @BCM_ALD @BCMDeptMedicine @BCM_Alumni

Registration is open for this day long CME conference with top notch speakers. You can attend in person or watch it from the comfort of your couch. @bcmhouston @CHESTAirways

Advances in Pulmonary Medicine 2026- Baylor College of Medicine #group-tabs-node-course-default1" target="_blank" rel="nofollow noopener">cpd.education.bcm.edu/content/advanc… @BCMLungInst @BCM_Lung @BCMCME @bcmhouston

@BCMLungInst @BCMCME @BCM_Lung

Obstructive Lung Disease Academy at #CHEST2025 @AdrishMD @BCMCME @BCMLungInst @BCM_Lung

Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial. thorax.bmj.com/content/80/9/6… @mathioudakisag

Registration is OPEN! Expand your knowledge & sharpen your skills at “Obstructive Lung Disease Academy: Hands-On Skills…Real Cases, Lasting Impact.” Saturday, October 18, 2025 Highlights of this session include: >Case-based discussions on #asthma, #COPD and #Bronchiectasis >Hands-on learning - Inhalers/airway clearance devices >Interactive group discussions >Games/Edutainment with @williamkellymd >All-star faculty line-up Sandra Adams, @Hananianick @maselliMD @JerryKrishnan, Barry Make, Sanjay Devaranjan, @basavarajashwin, De De Gardner, Praveen Akuthota, Richard Branson, Jei Li and Jesse Sherratt events.rdmobile.com/Sessions/Detai… @accpchest @CHESTAirways @Shahidisheikh11 #CHEST2025

@SeragHashem Congratulations Dr El-Serag on a very impactful work.

Honoured to coauthor this important report

Advances in Asthma Diagnosis and Management is now open for submissions until 5th January 2026. The link for the Call for Papers can be found here:  bmjopenrespres.bmj.com/pages/topic-co… @BMJOpen_Resp

INSIDE LOOK 👀 Read from the upcoming issue (July 8): Original research indicates that clinical remission is a realistic goal, sustainable up to two years in around one-third of patients w/ severe eosinophilic #asthma receiving benralizumab. hubs.la/Q03vrqbf0 #JournalCHEST

Presented at #CCR25: In a cluster-randomized, crossover trial, hospital-wide use of lactated Ringer’s solution as compared with normal saline did not alter the incidence of death or hospital readmission within 90 days. Full trial results: nej.md/45SaEBs @CritCareReviews

Based on the results of the MATINEE, METREX, AND METREO studies, mepolizumab is now FDA approved for patients with COPD and eosinophilia! An exciting new development in the world of COPD. #COPD #eosinophils

@williamkellymd Very well said sir!

Always go in person when asking for a consult if possible, and especially if it’s urgent. Just one of the benefits is getting to see colleagues and past trainees that have become the experts!

Do you remember when you joined X? I do! #MyXAnniversary

Original Article: First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate (PREDMETH trial) nej.md/4kdaf0o Editorial: Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis? nej.md/4mhaHfW #ATS2025 | @atscommunity

Kudos to Kate and Phil for putting together an impressive review!!